Poly Medicure share news, announcements and annual reports
NSE: POLYMEDBSE: 531768Healthcare Equipment & SuppliesSmall Cap
Poly Medicure Limited · Face value ₹5 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jun 1996 on BSE, Dec 2011 on NSE
Last close ₹1,461.90down ₹14.10 (0.96%)BSE ₹1,462.90
Share price at the NSE close on 29 Oct 2026. Previous close ₹1,476.00.
29 Oct: open ₹1,480.00, high ₹1,480.20, low ₹1,446.10
52-week range of traded prices to 29 Oct 2026
₹1,182.00Low, 30 Mar 2026₹2,094.30High, 11 Nov 2025
- Next results date: the board meets on 5 Nov 2026 to consider: financial results and other business matters. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹14,818 Cr425th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 47.03
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.77
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.24%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 10.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 9.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.11
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 36,08750.2% delivered
Poly Medicure disputes and clarifications
19 filed, newest first.
Jun 2026
Jan 2026
6 Jan · Legal
The exchange asked on 6 Jan 2026
Sep 2024
3 Sep · Legal
The exchange asked on 3 Sep 2024
Feb 2024
22 Feb · Legal
The exchange asked on 21 Feb 2024
Jul 2023
13 Jul · Legal
The exchange asked on 12 Jul 2023
Jun 2023
16 Jun · Legal
The exchange asked on 15 Jun 2023
Mar 2023
2 Mar · Legal
The exchange asked on 1 Mar 2023
Sep 2022
3 Sep · Legal
The exchange asked on 2 Sep 2022
Aug 2022
4 Aug · Legal
Exchange has sought clarification from Poly Medicure Limited with respect to announcement dated 04-Aug-2022 informing about Outcome of Board Meeting.On the basis of aforesaid announcement, the Company is required to provide/clarify the following: 1. Affirmation that the Director being appointed is not debarred from holding the office of director by virtue of any SEBI order or any other such authority The response of the company is awaited.
Feb 2021
6 Feb · Legal
The exchange asked on 5 Feb 2021
Oct 2020
17 Oct · Legal
The exchange asked on 16 Oct 2020
Sep 2020
14 Sep · Legal
Exchange has sought clarification from Poly Medicure Limited for the quarter ended 30-Jun-2020 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited.
Jul 2020
13 Jul · Legal
The exchange asked on 10 Jul 2020
May 2019
17 May · Legal
Exchange has sought clarification from Poly Medicure Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. The company has not submitted the Statement of Modified Opinion or in case of unmodified opinion(s), a declaration to that effect to the Stock Exchange. The response of the Company is awaited.
May 2018
11 May · Legal
Exchange has sought clarification from Poly Medicure Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. The company has not submitted the Statement of Modified Opinion or in case of unmodified opinion(s), a declaration to that effect to the Stock Exchange. The response of the Company is awaited.